Brief: Orchard Therapeutics- On March 24, 2023, Received Letter From Nasdaq Notifying It Had Regained Compliance With Nasdaq’S Minimum Bid Price Requirement
27/03/2023 21:42
March 27 (Reuters) - Orchard Therapeutics PLC OT10y.F :
* ORCHARD THERAPEUTICS- ON MARCH 24, 2023, RECEIVED LETTER
FROM
NASDAQ NOTIFYING IT HAD REGAINED COMPLIANCE WITH NASDAQ’S
MINIMUM BID PRICE REQUIREMENT
* ORCHARD THERAPEUTICS PLC - ON MARCH 23, 2023, ORCHARD
THERAPEUTICS PLC DELIVERED NOTICE TO MIDCAP FINANCIAL (IRELAND)
LIMITED
Further company coverage: OT10y.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orchard Therapeutics
See all newsBrief: Orchard Therapeutics Says Court Of Justice Of England & Wales Sanctioned Scheme Of Arrangement Providing For Acquisition Of Co By Kyowa Kirin Co's Unit
Brief: Orchard Therapeutics Receives U.S. FDA Fast Track Designation For OTL-203 In MPS-IH
Brief: Orchard Therapeutics Says U.S. FDA Advised Co It Does Not Intend To Schedule Advisory Committee Meeting
Orchard Therapeutics rises on buyout deal by Japanese drugmaker
Kyowa Kirin to acquire Orchard Therapeutics for $478 mln